[ad_1] I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 · Strategic reprioritization of the Company’s pipeline to focus on key clinical…
Tag: IMab
I-Mab : I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022
[ad_1] GAITHERSBURG – I-Mab (the ‘Company’) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its financial results for the 12…